Risklick developed the first of its kind, data-driven solution to design and optimize clinical trial protocols using AI. We empower experts to optimize medical and operational aspects of any given clinical study before start, thus performing cheaper, faster, and safer trials using empirical data. Risklick currently provides customer-centered solutions to diverse Biopharma and MedTech companies.
Risklick has developed an AI-based solution that is dedicated to protocol design and optimization and offers:
1) Background systematic information analysis based on historical data and integrates novelty live-monitoring.
2) State-of-the-art protocol design based on data-driven empirical data analysis for every step in designing protocol, including eligibility criteria and endpoints.
3) Risk-based analysis to optimize the medical and operational aspects of the clinical trial protocol prior to trial execution.
Risklick has developed an AI-based solution that is dedicated to protocol design and optimization and offers:
1) Background systematic information analysis based on historical data and integrates novelty live-monitoring.
2) State-of-the-art protocol design based on data-driven empirical data analysis for every step in designing protocol, including eligibility criteria and endpoints.
3) Risk-based analysis to optimize the medical and operational aspects of the clinical trial protocol prior to trial execution.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
